Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)
Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
4.750
+0.050 (1.06%)
At close: Dec 4, 2025

Jerusalem Pharmaceuticals Ratios and Metrics

Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
614949423635
Upgrade
Market Cap Growth
46.05%0.69%15.82%16.13%2.15%-1.04%
Upgrade
Enterprise Value
554341393739
Upgrade
Last Close Price
3.372.662.572.141.771.69
Upgrade
PE Ratio
8.6913.689.838.237.7213.39
Upgrade
PS Ratio
1.811.731.731.281.101.37
Upgrade
PB Ratio
1.030.960.990.910.740.81
Upgrade
P/TBV Ratio
1.071.001.030.940.800.89
Upgrade
P/FCF Ratio
22.106.948.723.6213.20111.66
Upgrade
P/OCF Ratio
14.025.877.443.478.4226.14
Upgrade
EV/Sales Ratio
1.641.521.471.181.121.50
Upgrade
EV/EBITDA Ratio
5.947.645.735.195.209.16
Upgrade
EV/EBIT Ratio
6.929.056.496.206.4813.58
Upgrade
EV/FCF Ratio
19.996.107.443.3513.40122.00
Upgrade
Debt / Equity Ratio
0.030.020.040.030.040.06
Upgrade
Debt / EBITDA Ratio
0.160.180.230.200.250.61
Upgrade
Debt / FCF Ratio
0.550.150.320.130.688.62
Upgrade
Asset Turnover
0.490.450.470.540.560.49
Upgrade
Inventory Turnover
2.082.101.721.791.611.40
Upgrade
Quick Ratio
2.543.342.972.882.802.49
Upgrade
Current Ratio
3.524.294.113.864.254.18
Upgrade
Return on Equity (ROE)
13.14%7.21%10.45%10.77%9.55%6.30%
Upgrade
Return on Assets (ROA)
7.32%4.77%6.60%6.45%6.06%3.38%
Upgrade
Return on Capital (ROIC)
9.05%5.80%8.09%7.94%7.29%4.03%
Upgrade
Return on Capital Employed (ROCE)
12.50%8.70%12.10%12.60%10.80%6.00%
Upgrade
Earnings Yield
11.52%7.31%10.17%12.15%12.95%7.47%
Upgrade
FCF Yield
4.53%14.42%11.46%27.64%7.58%0.90%
Upgrade
Dividend Yield
1.68%2.14%2.76%4.98%4.80%3.36%
Upgrade
Payout Ratio
14.34%33.52%36.63%29.90%20.25%44.33%
Upgrade
Buyback Yield / Dilution
-0.23%-----
Upgrade
Total Shareholder Return
1.45%2.14%2.76%4.98%4.80%3.36%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.